Johannes Drach
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis
Most-Cited Works
- → International Myeloma Working Group molecular classification of multiple myeloma: spotlight review(2009)875 cited
- → Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study(2011)720 cited
- → Genetics and Cytogenetics of Multiple Myeloma(2004)685 cited
- → D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study(2009)420 cited
- → Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma(2015)377 cited
- → Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study(2013)348 cited
- → Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy(1998)321 cited
- → Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization(2000)320 cited
- → Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype [see comments](1992)317 cited
- → Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality(2015)269 cited